CHRISTINE GUEBARA: Open Payments
NPI 1578513164 · GARDEN CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,047 in 11 payments from 8 companies in 2025. Trend: 2023 $115 · 2024 $130 · 2025 $2,047
Travel & lodging: $1,273Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 3 | $1,867 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, UZEDY, ABILIFY MAINTENA, Jornay PM, COBENFY, SPRAVATO, Auvelity, CAPLYTA.
Industry payments across KS — which companies pay providers there.
